数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
R. Lawrence Van Horn Director 52 18.15万美元 未持股 2020-03-15
Barbara R. Paul Director 66 17.98万美元 未持股 2020-03-15
Joseph A. Hastings Director 66 16.65万美元 未持股 2020-03-15
Terry Allison Rapphun Chair of the Board and Director 63 未披露 未持股 2020-03-15
Jon H. Kaplan Director 52 16.65万美元 未持股 2020-03-15
William P. Rutledge Director 65 17.49万美元 未持股 2020-03-15
Alice D. Schroeder Director 63 18.65万美元 未持股 2020-03-15
Robert H. Fish President, Chief Executive Officer and Director 69 107.04万美元 未持股 2020-03-15

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Alfred Lumsdaine Executive Vice President and Chief Financial Officer 54 87.47万美元 未持股 2020-03-15
R. Harold McCard, Jr. Senior Vice President, General Counsel and Secretary 59 58.06万美元 未持股 2020-03-15
Shaheed Koury President, Clinical Operations and Chief Medical Officer 53 73.73万美元 未持股 2020-03-15
Martin D. Smith Executive Vice President and Chief Operating Officer 52 97.38万美元 未持股 2020-03-15
Robert H. Fish President, Chief Executive Officer and Director 69 107.04万美元 未持股 2020-03-15

董事简历

中英对照 |  中文 |  英文
R. Lawrence Van Horn

R. Lawrence Van Horn,2006年起在Vanderbilt大学Owen管理研究生院担任经济和管理副教授,以及健康食物执行董事。他是一位健康管理和经济学顶尖专家和研究者。他目前的研究工作包括医疗市场的非盈利行为、管理和对象,以及医疗成果和效率的衡量。他在医疗机构非盈利医院管理激励以及管理护理公司行为的研究,发表在一些主要的出版刊物上。他为全国咨询公司、供应商、管理护理机构以及医药公司提供咨询服务。他还在Vanderbilt医学院和法学院担任院系的职位。在Owen的任期之前,1996-2006年,他曾在Rochester大学William E. Simon商学研究生院担任经济和管理学副教授,负责健康管理研究生项目。他持有Pennsylvania大学Wharton学院的博士学位,Rochester大学的工商管理硕士学位、公共卫生学士和硕士学位。


R. Lawrence Van Horn has been an associate professor of Economics and Management and the Executive Director of Health Affairs at the Vanderbilt University Owen Graduate School of Management "Owen" since 2006. Professor Van Horn is a leading expert and researcher on healthcare management and economics. His current research interests focus on the role of the consumer in health care markets and the measurement of healthcare outcomes and productivity. His research on healthcare organizations, managerial incentives in nonprofit hospitals and the conduct of managed care firms has appeared in leading publications, and media. Professor Van Horn consults for national consulting firms, providers, managed care organizations, and pharmaceutical firms as well as the federal government on topics of health policy. Professor Van Horn also holds faculty appointments in the Vanderbilt University School of Medicine and Law School. Prior to his tenure at Owen, from 1996 to 2006 Professor Van Horn served as an associate professor of economics and management at the William E. Simon Graduate School of Business at the University of Rochester where he was responsible for their graduate programs in health administration. Professor Van Horn previously served on the board of directors of Quorum Health Corporation until July 2020 and currently serves on the board of Harrow Inc. Professor Van Horn holds a Ph.D. from the University of Pennsylvania's Wharton School and a Master's in Business Administration, a Master's in Public Health and a B.A. from the University of Rochester.
R. Lawrence Van Horn,2006年起在Vanderbilt大学Owen管理研究生院担任经济和管理副教授,以及健康食物执行董事。他是一位健康管理和经济学顶尖专家和研究者。他目前的研究工作包括医疗市场的非盈利行为、管理和对象,以及医疗成果和效率的衡量。他在医疗机构非盈利医院管理激励以及管理护理公司行为的研究,发表在一些主要的出版刊物上。他为全国咨询公司、供应商、管理护理机构以及医药公司提供咨询服务。他还在Vanderbilt医学院和法学院担任院系的职位。在Owen的任期之前,1996-2006年,他曾在Rochester大学William E. Simon商学研究生院担任经济和管理学副教授,负责健康管理研究生项目。他持有Pennsylvania大学Wharton学院的博士学位,Rochester大学的工商管理硕士学位、公共卫生学士和硕士学位。
R. Lawrence Van Horn has been an associate professor of Economics and Management and the Executive Director of Health Affairs at the Vanderbilt University Owen Graduate School of Management "Owen" since 2006. Professor Van Horn is a leading expert and researcher on healthcare management and economics. His current research interests focus on the role of the consumer in health care markets and the measurement of healthcare outcomes and productivity. His research on healthcare organizations, managerial incentives in nonprofit hospitals and the conduct of managed care firms has appeared in leading publications, and media. Professor Van Horn consults for national consulting firms, providers, managed care organizations, and pharmaceutical firms as well as the federal government on topics of health policy. Professor Van Horn also holds faculty appointments in the Vanderbilt University School of Medicine and Law School. Prior to his tenure at Owen, from 1996 to 2006 Professor Van Horn served as an associate professor of economics and management at the William E. Simon Graduate School of Business at the University of Rochester where he was responsible for their graduate programs in health administration. Professor Van Horn previously served on the board of directors of Quorum Health Corporation until July 2020 and currently serves on the board of Harrow Inc. Professor Van Horn holds a Ph.D. from the University of Pennsylvania's Wharton School and a Master's in Business Administration, a Master's in Public Health and a B.A. from the University of Rochester.
Barbara R. Paul

BarbaraR.Paul担任梦百合公司的顾问和董事会成员。除了她在我们董事会的角色,她在董事会任职,并担任Natus Medical,Inc.的董事会主席。Nasdaq:NTUS是一家领先的梦百合产品和服务提供商,用于神经功能障碍、癫痫、睡眠障碍、新生儿护理、听力障碍以及平衡和行动障碍的筛查、检测、治疗、监测和跟踪。她曾担任CHS公司的高级副总裁兼首席医疗官(从2007年7月到2014年),领导多家医院的收购和整合,并负责加强公司与附属医生的关系、培养医生领导者和提供战略指导。在加入CHS之前,Paul博士是Beverly Enterprises,Inc.(现Golden Living,Inc.)的高级副总裁兼首席医疗官。从1999年到2004年,她曾任职the Federal Medicare Program(the Centers for Medicare&Medicaid Services,CMS),负责克林顿总统和布什总统的任命,在那里她曾担任质量测量和健康评估部门的董事。Paul博士在威斯康星大学麦迪逊分校(University of Wisconsin-Madison)获得理学学士学位,并在斯坦福大学医学院(Stanford University School of Medicine)获得医学学位。Paul博士的职业生涯建立在十二年作为董事会认证的内科医生和全职初级保健医生的基础上。


Barbara R. Paul serves as an advisor and board member to healthcare companies. In addition to her role on our Board, she serves on the board and as the board chair of Natus Medical, Inc. NASDAQ: NTUS, a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders. She served as Senior Vice President & Chief Medical Officer at CHS from July 2007 through 2014 providing leadership for a number of hospital acquisitions and integrations and being responsible for enhancing the company's relationship with affiliated physicians, developing physician leaders, and providing strategic direction. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.). From 1999 to 2004 she worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush, where she was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin-Madison and earned her medical degree from Stanford University School of Medicine. Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician.
BarbaraR.Paul担任梦百合公司的顾问和董事会成员。除了她在我们董事会的角色,她在董事会任职,并担任Natus Medical,Inc.的董事会主席。Nasdaq:NTUS是一家领先的梦百合产品和服务提供商,用于神经功能障碍、癫痫、睡眠障碍、新生儿护理、听力障碍以及平衡和行动障碍的筛查、检测、治疗、监测和跟踪。她曾担任CHS公司的高级副总裁兼首席医疗官(从2007年7月到2014年),领导多家医院的收购和整合,并负责加强公司与附属医生的关系、培养医生领导者和提供战略指导。在加入CHS之前,Paul博士是Beverly Enterprises,Inc.(现Golden Living,Inc.)的高级副总裁兼首席医疗官。从1999年到2004年,她曾任职the Federal Medicare Program(the Centers for Medicare&Medicaid Services,CMS),负责克林顿总统和布什总统的任命,在那里她曾担任质量测量和健康评估部门的董事。Paul博士在威斯康星大学麦迪逊分校(University of Wisconsin-Madison)获得理学学士学位,并在斯坦福大学医学院(Stanford University School of Medicine)获得医学学位。Paul博士的职业生涯建立在十二年作为董事会认证的内科医生和全职初级保健医生的基础上。
Barbara R. Paul serves as an advisor and board member to healthcare companies. In addition to her role on our Board, she serves on the board and as the board chair of Natus Medical, Inc. NASDAQ: NTUS, a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders. She served as Senior Vice President & Chief Medical Officer at CHS from July 2007 through 2014 providing leadership for a number of hospital acquisitions and integrations and being responsible for enhancing the company's relationship with affiliated physicians, developing physician leaders, and providing strategic direction. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.). From 1999 to 2004 she worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush, where she was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin-Madison and earned her medical degree from Stanford University School of Medicine. Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician.
Joseph A. Hastings

JosephA.Hastings是阿拉巴马州莫比尔的一名私人正畸医生。在阿拉斯加大学安克雷奇分校(University of Alaska Anchorage)任职两年后,他以优异成绩获得阿拉巴马大学伯明翰分校(the University of Alabama at Birmingham School of Dentry)的学士学位,并以优异成绩毕业于阿拉巴马大学伯明翰分校。他在新奥尔良the Louisiana State University School of Dentrestry完成博士后培训。Hastings博士在小型执业环境中的职业生涯是公司大多数设施的典型,他能够为董事会和管理层提供有关医学和医生执业的组织和运营趋势的建议。Hastings’博士曾在地方、州和国家协会担任多个牙科和正畸领导职位。他是董事会认证的正畸,并发表在几个正畸期刊上,包括全职私人执业出版。他拥有两项美国专利。


Joseph A. Hastings is a private practice orthodontist in Mobile, Alabama. After two years at the University of Alaska Anchorage he received a B.A. degree with Honors from the University of Alabama at Birmingham and graduated with honors from the University of Alabama at Birmingham School of Dentistry. He completed his post-doctoral training at the Louisiana State University School of Dentistry in New Orleans. Dr. Hastings' career in a small practice setting is typical to that of most of the company's facilities and he is able to provide advice to the Board and management about trends in both medicine and the organization and operation of physician practices. Dr. Hastings' has served in numerous dental and orthodontic leadership positions in local, state, and national societies. He is board certified in orthodontics and been published in several orthodontic journals including publishing while in full time private practice. He holds two United States patents.
JosephA.Hastings是阿拉巴马州莫比尔的一名私人正畸医生。在阿拉斯加大学安克雷奇分校(University of Alaska Anchorage)任职两年后,他以优异成绩获得阿拉巴马大学伯明翰分校(the University of Alabama at Birmingham School of Dentry)的学士学位,并以优异成绩毕业于阿拉巴马大学伯明翰分校。他在新奥尔良the Louisiana State University School of Dentrestry完成博士后培训。Hastings博士在小型执业环境中的职业生涯是公司大多数设施的典型,他能够为董事会和管理层提供有关医学和医生执业的组织和运营趋势的建议。Hastings’博士曾在地方、州和国家协会担任多个牙科和正畸领导职位。他是董事会认证的正畸,并发表在几个正畸期刊上,包括全职私人执业出版。他拥有两项美国专利。
Joseph A. Hastings is a private practice orthodontist in Mobile, Alabama. After two years at the University of Alaska Anchorage he received a B.A. degree with Honors from the University of Alabama at Birmingham and graduated with honors from the University of Alabama at Birmingham School of Dentistry. He completed his post-doctoral training at the Louisiana State University School of Dentistry in New Orleans. Dr. Hastings' career in a small practice setting is typical to that of most of the company's facilities and he is able to provide advice to the Board and management about trends in both medicine and the organization and operation of physician practices. Dr. Hastings' has served in numerous dental and orthodontic leadership positions in local, state, and national societies. He is board certified in orthodontics and been published in several orthodontic journals including publishing while in full time private practice. He holds two United States patents.
Terry Allison Rapphun

Terry Allison Rapphun自2018年3月起担任董事会主席。Rappuhn女士目前还担任Akorn,Inc.的董事。纳斯达克市场代码:AKRX,一家上市的专业制药公司,也是Genesis梦百合公司(纽约证券交易所市场代码:GEN)的董事,后者是一家全国性的急性后梦百合服务提供商。此前,Rappuhn女士曾担任Span-AmericaMedicalSystems,Inc.(2016-2017年),AGA Medical Holdings,Inc.(2006-2010年)和Genesis梦百合Corporation(2003-2007年)的董事会成员。从1999年到2001年4月,Rappuhn女士担任Quorum Health Group,Inc.(以前是一家上市公司,被Triad Hospitals,Inc.收购)的高级副总裁和首席财务官,该公司是一家急性护理医院的所有者和运营商。Rappuhn女士在公共梦百合公司建设基础设施、系统和团队的过程中拥有经验。她持有Middle Tennessee State University的工商管理学士学位,是一名注册会计师,在Ernst&Young,LLP有着十五年的经验。


Terry Allison Rapphun has served as Chair of the Board since March 2018. Ms. Rappuhn also currently serves as a director of Akorn, Inc. Nasdaq: AKRX, a publicly-held specialty pharmaceutical company, and a director of Genesis Healthcare Inc. (NYSE: GEN), a national provider of post-acute healthcare services. Previously, Ms. Rappuhn served on the boards of Span-America Medical Systems, Inc. (2016-2017), AGA Medical Holdings, Inc. (2006-2010) and Genesis HealthCare Corporation (2003-2007). From 1999 to April 2001 Ms. Rappuhn served as Senior Vice President and Chief Financial Officer of Quorum Health Group, Inc. (previously a publicly-held company that was acquired by Triad Hospitals, Inc.), an owner and operator of acute care hospitals. Ms. Rappuhn has experience with public healthcare companies in the process of building infrastructure, systems and teams. She holds a Bachelor of Business Administration from Middle Tennessee State University and is a Certified Public Accountant with fifteen years of experience with Ernst & Young, LLP.
Terry Allison Rapphun自2018年3月起担任董事会主席。Rappuhn女士目前还担任Akorn,Inc.的董事。纳斯达克市场代码:AKRX,一家上市的专业制药公司,也是Genesis梦百合公司(纽约证券交易所市场代码:GEN)的董事,后者是一家全国性的急性后梦百合服务提供商。此前,Rappuhn女士曾担任Span-AmericaMedicalSystems,Inc.(2016-2017年),AGA Medical Holdings,Inc.(2006-2010年)和Genesis梦百合Corporation(2003-2007年)的董事会成员。从1999年到2001年4月,Rappuhn女士担任Quorum Health Group,Inc.(以前是一家上市公司,被Triad Hospitals,Inc.收购)的高级副总裁和首席财务官,该公司是一家急性护理医院的所有者和运营商。Rappuhn女士在公共梦百合公司建设基础设施、系统和团队的过程中拥有经验。她持有Middle Tennessee State University的工商管理学士学位,是一名注册会计师,在Ernst&Young,LLP有着十五年的经验。
Terry Allison Rapphun has served as Chair of the Board since March 2018. Ms. Rappuhn also currently serves as a director of Akorn, Inc. Nasdaq: AKRX, a publicly-held specialty pharmaceutical company, and a director of Genesis Healthcare Inc. (NYSE: GEN), a national provider of post-acute healthcare services. Previously, Ms. Rappuhn served on the boards of Span-America Medical Systems, Inc. (2016-2017), AGA Medical Holdings, Inc. (2006-2010) and Genesis HealthCare Corporation (2003-2007). From 1999 to April 2001 Ms. Rappuhn served as Senior Vice President and Chief Financial Officer of Quorum Health Group, Inc. (previously a publicly-held company that was acquired by Triad Hospitals, Inc.), an owner and operator of acute care hospitals. Ms. Rappuhn has experience with public healthcare companies in the process of building infrastructure, systems and teams. She holds a Bachelor of Business Administration from Middle Tennessee State University and is a Certified Public Accountant with fifteen years of experience with Ernst & Young, LLP.
Jon H. Kaplan

JonH.Kaplan拥有丰富的业务经验,为梦百合公司提供咨询和建议。自2007年以来,他一直担任波士顿咨询集团(Boston Consulting Group,Inc.“BCG”)的高级合伙人兼董事总经理,该公司是一家专注于提供管理咨询服务的私营公司,他最近在BCG的全球领导委员会任职,并担任BCG梦百合服务的实践负责人。此前,他曾担任Ernst&Young公司的咨询部门的合伙人,在那里他曾任职10年以上。Kaplan先生在康奈尔大学(Cornell University)获得经济学学士学位,在匹兹堡大学(University of Pittsburgh)获得公共卫生硕士学位,在西北大学凯洛格管理研究生院(Kellogg Graduate School of Management)获得工商管理硕士学位。


Jon H. Kaplan has extensive business experience consulting and advising healthcare companies. Since 2007 he has served as a Senior Partner and Managing Director of the Boston Consulting Group, Inc. "BCG", a privately-held company focused on providing management consulting services, where he recently served on BCG's global leadership council and as the practice leader of BCG's healthcare services. Previously, Mr. Kaplan was a partner in the consulting division of Ernst & Young, where he served for over ten years. Mr. Kaplan received a B.A. in Economics from Cornell University, a Masters of Public Health from the University of Pittsburgh and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.
JonH.Kaplan拥有丰富的业务经验,为梦百合公司提供咨询和建议。自2007年以来,他一直担任波士顿咨询集团(Boston Consulting Group,Inc.“BCG”)的高级合伙人兼董事总经理,该公司是一家专注于提供管理咨询服务的私营公司,他最近在BCG的全球领导委员会任职,并担任BCG梦百合服务的实践负责人。此前,他曾担任Ernst&Young公司的咨询部门的合伙人,在那里他曾任职10年以上。Kaplan先生在康奈尔大学(Cornell University)获得经济学学士学位,在匹兹堡大学(University of Pittsburgh)获得公共卫生硕士学位,在西北大学凯洛格管理研究生院(Kellogg Graduate School of Management)获得工商管理硕士学位。
Jon H. Kaplan has extensive business experience consulting and advising healthcare companies. Since 2007 he has served as a Senior Partner and Managing Director of the Boston Consulting Group, Inc. "BCG", a privately-held company focused on providing management consulting services, where he recently served on BCG's global leadership council and as the practice leader of BCG's healthcare services. Previously, Mr. Kaplan was a partner in the consulting division of Ernst & Young, where he served for over ten years. Mr. Kaplan received a B.A. in Economics from Cornell University, a Masters of Public Health from the University of Pittsburgh and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.
William P. Rutledge

WilliamP.Rutledge在医疗保健行业拥有40多年的经验,目前担任梦百合公司的顾问和董事会成员。Rutledge先生自2017年10月起担任Shore Capital Partners,LLC(一家专注于梦百合的私募股权公司)投资组合公司的董事会成员,并于2019年加入该公司担任执行合伙人。自2014年以来,他一直担任Clayton Associates(一家专注于梦百合的风险投资基金)的顾问委员会成员。他曾担任Chinaco梦百合Corporation的首席执行官(从2016年1月到2017年4月该公司出售给亚洲私募股权基金)。此前,拉特利奇在HCAHealthcare,Inc.度过了大约30年的职业生涯。NYSE:HCA,最近从2005年10月到2013年3月担任HCA Central Group总裁。他也曾担任American Hospital Association、the Tennessee Hospital Association和美国医院联合会的董事。Rutledge先生在佐治亚大学(University of Georgia)获得学士学位,并在佐治亚州立大学(Georgia State University)获得卫生管理硕士学位。


William P. Rutledge has over 40 years of experience in the health care industry and currently serves as an advisor and board member to healthcare companies. Since October 2017 Mr. Rutledge has served on the board of directors for portfolio companies of Shore Capital Partners, LLC, a healthcare-focused private equity firm, and in 2019 joined the firm as an Executive Partner. Since 2014 he has served on the advisory board of Clayton Associates, a healthcare-focused venture capital fund. He served as CEO of Chinaco Healthcare Corporation from January 2016 through completion of its sale to an Asian private equity fund in April 2017. Previously, Mr. Rutledge spent approximately thirty years of his career at HCA Healthcare, Inc. NYSE: HCA, most recently serving as the President of the HCA Central Group from October 2005 through March 2013. He has also served as a director of the American Hospital Association, the Tennessee Hospital Association and the Federation of American Hospitals. Mr. Rutledge earned a B.S. from the University of Georgia and a Masters of Health Administration from Georgia State University.
WilliamP.Rutledge在医疗保健行业拥有40多年的经验,目前担任梦百合公司的顾问和董事会成员。Rutledge先生自2017年10月起担任Shore Capital Partners,LLC(一家专注于梦百合的私募股权公司)投资组合公司的董事会成员,并于2019年加入该公司担任执行合伙人。自2014年以来,他一直担任Clayton Associates(一家专注于梦百合的风险投资基金)的顾问委员会成员。他曾担任Chinaco梦百合Corporation的首席执行官(从2016年1月到2017年4月该公司出售给亚洲私募股权基金)。此前,拉特利奇在HCAHealthcare,Inc.度过了大约30年的职业生涯。NYSE:HCA,最近从2005年10月到2013年3月担任HCA Central Group总裁。他也曾担任American Hospital Association、the Tennessee Hospital Association和美国医院联合会的董事。Rutledge先生在佐治亚大学(University of Georgia)获得学士学位,并在佐治亚州立大学(Georgia State University)获得卫生管理硕士学位。
William P. Rutledge has over 40 years of experience in the health care industry and currently serves as an advisor and board member to healthcare companies. Since October 2017 Mr. Rutledge has served on the board of directors for portfolio companies of Shore Capital Partners, LLC, a healthcare-focused private equity firm, and in 2019 joined the firm as an Executive Partner. Since 2014 he has served on the advisory board of Clayton Associates, a healthcare-focused venture capital fund. He served as CEO of Chinaco Healthcare Corporation from January 2016 through completion of its sale to an Asian private equity fund in April 2017. Previously, Mr. Rutledge spent approximately thirty years of his career at HCA Healthcare, Inc. NYSE: HCA, most recently serving as the President of the HCA Central Group from October 2005 through March 2013. He has also served as a director of the American Hospital Association, the Tennessee Hospital Association and the Federation of American Hospitals. Mr. Rutledge earned a B.S. from the University of Georgia and a Masters of Health Administration from Georgia State University.
Alice D. Schroeder

AliceD.Schroeder是一名前金融分析师和注册会计师,她曾担任包括金融机构在内的各种业务的董事会成员。2013年以来,她曾一直任职Prudential plc(FTSE20金融服务公司)的董事会,在那里她曾担任审计和风险委员会的成员。她也任职于Natus Medical,Inc.的董事会。Nasdaq:NTUS,她是审计委员会成员和提名与治理委员会主席。从2016年2月至2018年12月,她担任金融机构美国银行公司(纽约证券交易所代码:BAC)的子公司美银美林国际(Bank of America Merrill Lynch International)的董事会成员,审计委员会主席和治理委员会成员。从2014年10月到2017年5月出售给Showfer Media LLC,施罗德女士担任媒体软件平台开发商WebTuner Corporation的首席执行官兼董事会主席。她的职业生涯始于安永会计师事务所(Ernst&Young)的注册会计师,并在财务会计准则委员会(the Financial Accounting Standards Board)担任了两年的项目经理,在那里她是几个关键会计准则的主要作者。Schroeder女士曾担任摩根士丹利,PaineWebber&Co.和CIBC Oppenheimer&Co.的常务董事,在那里她从1993年开始领导获奖的研究分析师团队。Schroeder女士拥有德克萨斯大学奥斯汀分校(University of Texas at Austin)的工商管理硕士学位和工商管理学士学位。


Alice D. Schroeder is a former financial analyst and Certified Public Accountant, and she has served as a board member for various businesses, including financial institutions. Since 2013 she has served on the board of Prudential plc, a FTSE 20 financial services company, where she is a member of the audit and risk committees. She also serves on the board of Natus Medical, Inc. NASDAQ: NTUS, where she is a member of the audit committee and chair of the nominating and governance committee. From February 2016 until December 2018 she served as a board member, chair of the audit committee and member of the governance committee of Bank of America Merrill Lynch International, a subsidiary of Bank of America Corporation (NYSE: BAC), a financial institution. From October 2014 to its sale to Showfer Media LLC in May 2017 Ms. Schroeder served as CEO and chair of the board of directors of WebTuner Corporation, a developer of media software platforms. She began her career as a Certified Public Accountant at Ernst & Young and spent two years as a project manager at the Financial Accounting Standards Board, where she was the primary author of several key accounting standards. Ms. Schroeder was a managing director at Morgan Stanley, PaineWebber & Co. and CIBC Oppenheimer & Co., where she led award-winning research analyst teams beginning in 1993. Ms. Schroeder holds M.B.A. and B.B.A. degrees from The University of Texas at Austin.
AliceD.Schroeder是一名前金融分析师和注册会计师,她曾担任包括金融机构在内的各种业务的董事会成员。2013年以来,她曾一直任职Prudential plc(FTSE20金融服务公司)的董事会,在那里她曾担任审计和风险委员会的成员。她也任职于Natus Medical,Inc.的董事会。Nasdaq:NTUS,她是审计委员会成员和提名与治理委员会主席。从2016年2月至2018年12月,她担任金融机构美国银行公司(纽约证券交易所代码:BAC)的子公司美银美林国际(Bank of America Merrill Lynch International)的董事会成员,审计委员会主席和治理委员会成员。从2014年10月到2017年5月出售给Showfer Media LLC,施罗德女士担任媒体软件平台开发商WebTuner Corporation的首席执行官兼董事会主席。她的职业生涯始于安永会计师事务所(Ernst&Young)的注册会计师,并在财务会计准则委员会(the Financial Accounting Standards Board)担任了两年的项目经理,在那里她是几个关键会计准则的主要作者。Schroeder女士曾担任摩根士丹利,PaineWebber&Co.和CIBC Oppenheimer&Co.的常务董事,在那里她从1993年开始领导获奖的研究分析师团队。Schroeder女士拥有德克萨斯大学奥斯汀分校(University of Texas at Austin)的工商管理硕士学位和工商管理学士学位。
Alice D. Schroeder is a former financial analyst and Certified Public Accountant, and she has served as a board member for various businesses, including financial institutions. Since 2013 she has served on the board of Prudential plc, a FTSE 20 financial services company, where she is a member of the audit and risk committees. She also serves on the board of Natus Medical, Inc. NASDAQ: NTUS, where she is a member of the audit committee and chair of the nominating and governance committee. From February 2016 until December 2018 she served as a board member, chair of the audit committee and member of the governance committee of Bank of America Merrill Lynch International, a subsidiary of Bank of America Corporation (NYSE: BAC), a financial institution. From October 2014 to its sale to Showfer Media LLC in May 2017 Ms. Schroeder served as CEO and chair of the board of directors of WebTuner Corporation, a developer of media software platforms. She began her career as a Certified Public Accountant at Ernst & Young and spent two years as a project manager at the Financial Accounting Standards Board, where she was the primary author of several key accounting standards. Ms. Schroeder was a managing director at Morgan Stanley, PaineWebber & Co. and CIBC Oppenheimer & Co., where she led award-winning research analyst teams beginning in 1993. Ms. Schroeder holds M.B.A. and B.B.A. degrees from The University of Texas at Austin.
Robert H. Fish

Robert H. Fish,2013年11年起担任本公司董事;当时,他刚加入本公司,担任首席执行官。整个职业生涯中,他在多个医疗保健公司中担任过董事长、总裁、首席执行官。2012年到2013年加入本公司期间,他是Sonoma-Seacrest, LLC的管理合伙人,这是加利福尼亚的一家医疗保健行业公司,专门从事战略规划、绩效改进、并购方面的事务。2008-2012,他担任REACH Medical Holdings的董事长,这是一家地区性的空中医疗运输公司;2005-2006,担任Coram的执行董事长,这是大型的家用输液供应商;2002-2004,担任Genesis Health Ventures的董事长、首席执行官,这是一个长期护理与公共机构药物公司。他从2013年起,担任St. Helena Hospital Foundation的董事,这是位于北加州的非营利机构。他还曾担任St. Joseph Health System - Sonoma County 和 Valleycare Health System的总裁、首席执行官,上述两机构都是位于北加州的区域性医院系统。


Robert H. Fish has served as a member of the Board since 2017. Mr. Fish has served, since May 2018 as Chief Executive Officer and, since September 2018 as a member of the board of directors of Quorum Health Corporation, an operator of general acute care hospitals and outpatient services. Prior to joining Quorum Health, he served as Interim Chief Executive Officer of Millennium Health, LLC from January 2018 to March 2018. Mr. Fish also serves as the Chairman of the board of directors of Genesis Healthcare, Inc., a national provider of post-acute healthcare services “Genesis”. Mr. Fish joined Skilled Healthcare Group, Inc., which was later acquired by Genesis, as the Chief Executive Officer in 2013. Mr. Fish served as Skilled Healthcare’s Chief Executive Officer until February 2015 when the combination of Skilled Healthcare and Genesis was completed. During his career, Mr. Fish has served as Chairman, President or Chief Executive Officer of a number of public and private healthcare services companies. From 2012 until he joined Skilled Healthcare in 2013 Mr. Fish served as Managing Partner of Sonoma-Seacrest, LLC, a California health care firm specializing in strategic planning, performance improvement and merger and acquisition matters. Mr. Fish’s prior board positions include serving as the Chairman of REACH Medical Holdings, a regional air medical transport company, from 2008 to 2012 which was acquired by Air Medical Group Holdings; serving as the Executive Chairman of Coram, Inc., a large home infusion provider, from 2005 to 2006 until its sale to Apria; serving as a director of NeighborCare, Inc., a large institutional pharmacy, from 2003 to 2005 until its acquisition by Omnicare; and serving as the Lead Director of Genesis from 2003 to 2007. From 2001 to 2002 Mr. Fish served as a director and subsequently from 2002 to 2003 Mr. Fish served as Chairman and Chief Executive Officer of Genesis Health Ventures, a long-term care and institutional pharmacy company and predecessor in interest to Genesis. Mr. Fish also has extensive experience in hospital administration, having been President and Chief Executive Officer of St. Joseph Health System from 1995 to 1999 and Valley Care Health System from 1985 to 1995 as well as a member of the Board of Directors of the St. Helena Hospital Foundation, a philanthropic organization benefiting the St. Helena Hospitals in Napa Valley, since 2013. Mr. Fish received a B.A. degree in Sociology from Whittier College and a M.P.H. degree in Hospital Administration from the University of California, Berkeley.
Robert H. Fish,2013年11年起担任本公司董事;当时,他刚加入本公司,担任首席执行官。整个职业生涯中,他在多个医疗保健公司中担任过董事长、总裁、首席执行官。2012年到2013年加入本公司期间,他是Sonoma-Seacrest, LLC的管理合伙人,这是加利福尼亚的一家医疗保健行业公司,专门从事战略规划、绩效改进、并购方面的事务。2008-2012,他担任REACH Medical Holdings的董事长,这是一家地区性的空中医疗运输公司;2005-2006,担任Coram的执行董事长,这是大型的家用输液供应商;2002-2004,担任Genesis Health Ventures的董事长、首席执行官,这是一个长期护理与公共机构药物公司。他从2013年起,担任St. Helena Hospital Foundation的董事,这是位于北加州的非营利机构。他还曾担任St. Joseph Health System - Sonoma County 和 Valleycare Health System的总裁、首席执行官,上述两机构都是位于北加州的区域性医院系统。
Robert H. Fish has served as a member of the Board since 2017. Mr. Fish has served, since May 2018 as Chief Executive Officer and, since September 2018 as a member of the board of directors of Quorum Health Corporation, an operator of general acute care hospitals and outpatient services. Prior to joining Quorum Health, he served as Interim Chief Executive Officer of Millennium Health, LLC from January 2018 to March 2018. Mr. Fish also serves as the Chairman of the board of directors of Genesis Healthcare, Inc., a national provider of post-acute healthcare services “Genesis”. Mr. Fish joined Skilled Healthcare Group, Inc., which was later acquired by Genesis, as the Chief Executive Officer in 2013. Mr. Fish served as Skilled Healthcare’s Chief Executive Officer until February 2015 when the combination of Skilled Healthcare and Genesis was completed. During his career, Mr. Fish has served as Chairman, President or Chief Executive Officer of a number of public and private healthcare services companies. From 2012 until he joined Skilled Healthcare in 2013 Mr. Fish served as Managing Partner of Sonoma-Seacrest, LLC, a California health care firm specializing in strategic planning, performance improvement and merger and acquisition matters. Mr. Fish’s prior board positions include serving as the Chairman of REACH Medical Holdings, a regional air medical transport company, from 2008 to 2012 which was acquired by Air Medical Group Holdings; serving as the Executive Chairman of Coram, Inc., a large home infusion provider, from 2005 to 2006 until its sale to Apria; serving as a director of NeighborCare, Inc., a large institutional pharmacy, from 2003 to 2005 until its acquisition by Omnicare; and serving as the Lead Director of Genesis from 2003 to 2007. From 2001 to 2002 Mr. Fish served as a director and subsequently from 2002 to 2003 Mr. Fish served as Chairman and Chief Executive Officer of Genesis Health Ventures, a long-term care and institutional pharmacy company and predecessor in interest to Genesis. Mr. Fish also has extensive experience in hospital administration, having been President and Chief Executive Officer of St. Joseph Health System from 1995 to 1999 and Valley Care Health System from 1985 to 1995 as well as a member of the Board of Directors of the St. Helena Hospital Foundation, a philanthropic organization benefiting the St. Helena Hospitals in Napa Valley, since 2013. Mr. Fish received a B.A. degree in Sociology from Whittier College and a M.P.H. degree in Hospital Administration from the University of California, Berkeley.

高管简历

中英对照 |  中文 |  英文
Alfred Lumsdaine

Alfred Lumsdaine,2002年加入Healthways, Inc. "Healthways",2011年成为财务总监。作为Healthways的财务总监,他负责企业风险管理,包括所有的财务职能部门、投资者关系、监管合规、采购和项目管理。此前,他在Healthways担任总会计师和首席会计官,负责会计、金库、税务、财务报告、内部审计和公司系统。他此前的职业经历专注于医疗服务。此前,2001-2002年,在Logisco, Inc.担任司库和总会计师;此前,1998-2000年,在Beverly Rehabilitation(Beverly Enterprises的一个分部)担任高级财务职位;1998-2000年,在Theraphysics。1996-1997年,领导Willis的北美洲内部审计部门。他在Ernst & Young的Nashville办事处开始他的职业生涯的,在该公司工作了超过8年;1988-1996年从事外部审计业务,主要在医疗行业。曾领导和支持了重要的并购活动和资本市场交易,他的财务领导经历扩展从小型快速发展私营实体到有财务报告需求的大型综合会计公共公司。他持有Tennessee大学的会计学士学位和会计硕士学位,是一名注册会计师。


Alfred Lumsdaine serves as Executive Vice President and Chief Financial Officer. Prior to joining the Company in January 2018 Mr. Lumsdaine served as President of Population Health for Sharecare, Inc., a digital health company, a position he held since 2016. Prior to joining Sharecare, Mr. Lumsdaine served as Chief Financial Officer of Tivity Health, Inc. f/k/a Healthways, Inc. (Nasdaq: TVTY), a provider of fitness activity programs, since 2011. Previously, Mr. Lumsdaine was Controller and Chief Accounting Officer at Tivity Health, Inc., a role he assumed in 2002 when he first joined the company. Prior to joining Tivity Health, Inc., Mr. Lumsdaine held the position of Treasurer and Controller for Logisco, Inc., which followed senior level financial positions with Aegis Therapies and Theraphysics, a provider of rehabilitation and wellness services. Mr. Lumsdaine started his career with the Nashville office of Ernst & Young, spending over eight years in the external audit practice, primarily focused on the healthcare industry, and subsequently directed the North America internal audit department of Willis. Mr. Lumsdaine is a Certified Public Accountant and earned both his B.S. in Accounting and Masters of Accountancy from the University of Tennessee.
Alfred Lumsdaine,2002年加入Healthways, Inc. "Healthways",2011年成为财务总监。作为Healthways的财务总监,他负责企业风险管理,包括所有的财务职能部门、投资者关系、监管合规、采购和项目管理。此前,他在Healthways担任总会计师和首席会计官,负责会计、金库、税务、财务报告、内部审计和公司系统。他此前的职业经历专注于医疗服务。此前,2001-2002年,在Logisco, Inc.担任司库和总会计师;此前,1998-2000年,在Beverly Rehabilitation(Beverly Enterprises的一个分部)担任高级财务职位;1998-2000年,在Theraphysics。1996-1997年,领导Willis的北美洲内部审计部门。他在Ernst & Young的Nashville办事处开始他的职业生涯的,在该公司工作了超过8年;1988-1996年从事外部审计业务,主要在医疗行业。曾领导和支持了重要的并购活动和资本市场交易,他的财务领导经历扩展从小型快速发展私营实体到有财务报告需求的大型综合会计公共公司。他持有Tennessee大学的会计学士学位和会计硕士学位,是一名注册会计师。
Alfred Lumsdaine serves as Executive Vice President and Chief Financial Officer. Prior to joining the Company in January 2018 Mr. Lumsdaine served as President of Population Health for Sharecare, Inc., a digital health company, a position he held since 2016. Prior to joining Sharecare, Mr. Lumsdaine served as Chief Financial Officer of Tivity Health, Inc. f/k/a Healthways, Inc. (Nasdaq: TVTY), a provider of fitness activity programs, since 2011. Previously, Mr. Lumsdaine was Controller and Chief Accounting Officer at Tivity Health, Inc., a role he assumed in 2002 when he first joined the company. Prior to joining Tivity Health, Inc., Mr. Lumsdaine held the position of Treasurer and Controller for Logisco, Inc., which followed senior level financial positions with Aegis Therapies and Theraphysics, a provider of rehabilitation and wellness services. Mr. Lumsdaine started his career with the Nashville office of Ernst & Young, spending over eight years in the external audit practice, primarily focused on the healthcare industry, and subsequently directed the North America internal audit department of Willis. Mr. Lumsdaine is a Certified Public Accountant and earned both his B.S. in Accounting and Masters of Accountancy from the University of Tennessee.
R. Harold McCard, Jr.

R.HaroldMcCard,Jr.担任高级副总裁,总法律顾问和秘书。McCard先生负责Quorum Health Corporation的所有法律事务。McCard先生自2016年4月我们分拆以来一直担任公司执行官。在分拆之前,McCard先生担任CHS的运营副总法律顾问,并负责管理支持部门运营的法律团队。McCard先生于2007年加入CHS,担任Vice President和助理总法律顾问。他是普林斯顿大学(Princeton University)和默瑟大学(Mercer University)沃尔特·乔治法学院(Walter F.George School of Law)的毕业生。


R. Harold McCard, Jr. serves as Senior Vice President, General Counsel and Secretary. Mr. McCard oversees all legal aspects for Quorum Health Corporation. Mr. McCard has been an executive officer of the Company since our Spin-off in April 2016. Prior to the Spin-off, Mr. McCard served as Deputy General Counsel - Operations for CHS and was responsible for managing the legal teams that supported Division operations. Mr. McCard joined CHS in 2007 as Vice President and Associate General Counsel. He is a graduate of Princeton University and the Walter F. George School of Law at Mercer University.
R.HaroldMcCard,Jr.担任高级副总裁,总法律顾问和秘书。McCard先生负责Quorum Health Corporation的所有法律事务。McCard先生自2016年4月我们分拆以来一直担任公司执行官。在分拆之前,McCard先生担任CHS的运营副总法律顾问,并负责管理支持部门运营的法律团队。McCard先生于2007年加入CHS,担任Vice President和助理总法律顾问。他是普林斯顿大学(Princeton University)和默瑟大学(Mercer University)沃尔特·乔治法学院(Walter F.George School of Law)的毕业生。
R. Harold McCard, Jr. serves as Senior Vice President, General Counsel and Secretary. Mr. McCard oversees all legal aspects for Quorum Health Corporation. Mr. McCard has been an executive officer of the Company since our Spin-off in April 2016. Prior to the Spin-off, Mr. McCard served as Deputy General Counsel - Operations for CHS and was responsible for managing the legal teams that supported Division operations. Mr. McCard joined CHS in 2007 as Vice President and Associate General Counsel. He is a graduate of Princeton University and the Walter F. George School of Law at Mercer University.
Shaheed Koury

Shaheed Koury担任临床运营总裁和首席医疗官。Koury博士自2016年4月我们分拆以来一直担任公司的执行官。分拆之前,他曾担任CHS公司的负责质量和临床转型的Vice President,在那里他曾领导几个CHS市场的临床集成网络的开发和实施。Koury博士此前曾在印第安纳州韦恩堡(Fort Wayne)和俄亥俄州辛辛那提(Cincinnati)担任急诊科医生,并在肯塔基大学(University of Kentucky)的紧急医学住院医师项目担任助理教授。Koury博士在肯塔基大学(University of Kentucky)获得医学学位。他在北卡罗来纳州格林维尔的东卡罗莱纳大学(East Carolina University)完成紧急医学住院医师。Koury博士在印第安纳州韦恩堡的印第安纳卫斯理大学(Indiana Wesleyan University)获得工商管理硕士学位,专注于医疗保健管理。他撰写并发表了几篇医疗保健领域的论文,并在几次全国会议上发表。


Shaheed Koury serves as President, Clinical Operations and Chief Medical Officer. Dr. Koury has been an executive officer of the Company since our Spin-off in April 2016. Prior to the Spin-off, he served as Vice President for Quality and Clinical Transformation for CHS, where he led development and implementation of clinically-integrated networks for several CHS markets. Dr. Koury previously worked as an emergency department physician in Fort Wayne, Indiana and Cincinnati, Ohio and was an Assistant Professor at the University of Kentucky’s Emergency Medicine Residency Program. Dr. Koury received his medical degree at the University of Kentucky. He completed an emergency medicine residency at East Carolina University in Greenville, North Carolina. Dr. Koury earned his M.B.A. with a focus in Health Care Management from Indiana Wesleyan University in Fort Wayne, Indiana. He has written and published several papers in the health care field and presented at several national meetings.
Shaheed Koury担任临床运营总裁和首席医疗官。Koury博士自2016年4月我们分拆以来一直担任公司的执行官。分拆之前,他曾担任CHS公司的负责质量和临床转型的Vice President,在那里他曾领导几个CHS市场的临床集成网络的开发和实施。Koury博士此前曾在印第安纳州韦恩堡(Fort Wayne)和俄亥俄州辛辛那提(Cincinnati)担任急诊科医生,并在肯塔基大学(University of Kentucky)的紧急医学住院医师项目担任助理教授。Koury博士在肯塔基大学(University of Kentucky)获得医学学位。他在北卡罗来纳州格林维尔的东卡罗莱纳大学(East Carolina University)完成紧急医学住院医师。Koury博士在印第安纳州韦恩堡的印第安纳卫斯理大学(Indiana Wesleyan University)获得工商管理硕士学位,专注于医疗保健管理。他撰写并发表了几篇医疗保健领域的论文,并在几次全国会议上发表。
Shaheed Koury serves as President, Clinical Operations and Chief Medical Officer. Dr. Koury has been an executive officer of the Company since our Spin-off in April 2016. Prior to the Spin-off, he served as Vice President for Quality and Clinical Transformation for CHS, where he led development and implementation of clinically-integrated networks for several CHS markets. Dr. Koury previously worked as an emergency department physician in Fort Wayne, Indiana and Cincinnati, Ohio and was an Assistant Professor at the University of Kentucky’s Emergency Medicine Residency Program. Dr. Koury received his medical degree at the University of Kentucky. He completed an emergency medicine residency at East Carolina University in Greenville, North Carolina. Dr. Koury earned his M.B.A. with a focus in Health Care Management from Indiana Wesleyan University in Fort Wayne, Indiana. He has written and published several papers in the health care field and presented at several national meetings.
Martin D. Smith

Martin D. Smith,他现担任部门总裁,负责III运营部事务。他于1998年进入本公司并担任医院首席执行官。他于2005年担任副总裁,负责集团运营事务。他于2008年晋升为部门总裁。他负责监管本公司位于伊利诺斯州、田纳西州和西佛吉尼亚州的多家附属医院。在进入本公司前,他曾在Health Management Associates公司担任多个行政职务。他在田纳西州大学(University of Tennessee。)获得工商硕士学位。


Martin D. Smith serves as Executive Vice President and Chief Operating Officer. In that position he oversees our hospital operations, as well as strategic growth initiatives. Mr. Smith has been an executive officer of the Company since our Spin-off in April 2016. Prior to the Spin-off, Mr. Smith served as Division III President of Operations for CHS with operational and management responsibilities for 35 affiliated hospitals in Illinois, Kentucky, Tennessee and West Virginia. He joined CHS in 1998 as a hospital CEO in Cleveland, Tennessee. In 2005 Mr. Smith was named a vice president of group operations, and he was promoted to Division President in 2008. Mr. Smith holds an M.B.A. from the University of Tennessee.
Martin D. Smith,他现担任部门总裁,负责III运营部事务。他于1998年进入本公司并担任医院首席执行官。他于2005年担任副总裁,负责集团运营事务。他于2008年晋升为部门总裁。他负责监管本公司位于伊利诺斯州、田纳西州和西佛吉尼亚州的多家附属医院。在进入本公司前,他曾在Health Management Associates公司担任多个行政职务。他在田纳西州大学(University of Tennessee。)获得工商硕士学位。
Martin D. Smith serves as Executive Vice President and Chief Operating Officer. In that position he oversees our hospital operations, as well as strategic growth initiatives. Mr. Smith has been an executive officer of the Company since our Spin-off in April 2016. Prior to the Spin-off, Mr. Smith served as Division III President of Operations for CHS with operational and management responsibilities for 35 affiliated hospitals in Illinois, Kentucky, Tennessee and West Virginia. He joined CHS in 1998 as a hospital CEO in Cleveland, Tennessee. In 2005 Mr. Smith was named a vice president of group operations, and he was promoted to Division President in 2008. Mr. Smith holds an M.B.A. from the University of Tennessee.
Robert H. Fish

Robert H. Fish,2013年11年起担任本公司董事;当时,他刚加入本公司,担任首席执行官。整个职业生涯中,他在多个医疗保健公司中担任过董事长、总裁、首席执行官。2012年到2013年加入本公司期间,他是Sonoma-Seacrest, LLC的管理合伙人,这是加利福尼亚的一家医疗保健行业公司,专门从事战略规划、绩效改进、并购方面的事务。2008-2012,他担任REACH Medical Holdings的董事长,这是一家地区性的空中医疗运输公司;2005-2006,担任Coram的执行董事长,这是大型的家用输液供应商;2002-2004,担任Genesis Health Ventures的董事长、首席执行官,这是一个长期护理与公共机构药物公司。他从2013年起,担任St. Helena Hospital Foundation的董事,这是位于北加州的非营利机构。他还曾担任St. Joseph Health System - Sonoma County 和 Valleycare Health System的总裁、首席执行官,上述两机构都是位于北加州的区域性医院系统。


Robert H. Fish has served as a member of the Board since 2017. Mr. Fish has served, since May 2018 as Chief Executive Officer and, since September 2018 as a member of the board of directors of Quorum Health Corporation, an operator of general acute care hospitals and outpatient services. Prior to joining Quorum Health, he served as Interim Chief Executive Officer of Millennium Health, LLC from January 2018 to March 2018. Mr. Fish also serves as the Chairman of the board of directors of Genesis Healthcare, Inc., a national provider of post-acute healthcare services “Genesis”. Mr. Fish joined Skilled Healthcare Group, Inc., which was later acquired by Genesis, as the Chief Executive Officer in 2013. Mr. Fish served as Skilled Healthcare’s Chief Executive Officer until February 2015 when the combination of Skilled Healthcare and Genesis was completed. During his career, Mr. Fish has served as Chairman, President or Chief Executive Officer of a number of public and private healthcare services companies. From 2012 until he joined Skilled Healthcare in 2013 Mr. Fish served as Managing Partner of Sonoma-Seacrest, LLC, a California health care firm specializing in strategic planning, performance improvement and merger and acquisition matters. Mr. Fish’s prior board positions include serving as the Chairman of REACH Medical Holdings, a regional air medical transport company, from 2008 to 2012 which was acquired by Air Medical Group Holdings; serving as the Executive Chairman of Coram, Inc., a large home infusion provider, from 2005 to 2006 until its sale to Apria; serving as a director of NeighborCare, Inc., a large institutional pharmacy, from 2003 to 2005 until its acquisition by Omnicare; and serving as the Lead Director of Genesis from 2003 to 2007. From 2001 to 2002 Mr. Fish served as a director and subsequently from 2002 to 2003 Mr. Fish served as Chairman and Chief Executive Officer of Genesis Health Ventures, a long-term care and institutional pharmacy company and predecessor in interest to Genesis. Mr. Fish also has extensive experience in hospital administration, having been President and Chief Executive Officer of St. Joseph Health System from 1995 to 1999 and Valley Care Health System from 1985 to 1995 as well as a member of the Board of Directors of the St. Helena Hospital Foundation, a philanthropic organization benefiting the St. Helena Hospitals in Napa Valley, since 2013. Mr. Fish received a B.A. degree in Sociology from Whittier College and a M.P.H. degree in Hospital Administration from the University of California, Berkeley.
Robert H. Fish,2013年11年起担任本公司董事;当时,他刚加入本公司,担任首席执行官。整个职业生涯中,他在多个医疗保健公司中担任过董事长、总裁、首席执行官。2012年到2013年加入本公司期间,他是Sonoma-Seacrest, LLC的管理合伙人,这是加利福尼亚的一家医疗保健行业公司,专门从事战略规划、绩效改进、并购方面的事务。2008-2012,他担任REACH Medical Holdings的董事长,这是一家地区性的空中医疗运输公司;2005-2006,担任Coram的执行董事长,这是大型的家用输液供应商;2002-2004,担任Genesis Health Ventures的董事长、首席执行官,这是一个长期护理与公共机构药物公司。他从2013年起,担任St. Helena Hospital Foundation的董事,这是位于北加州的非营利机构。他还曾担任St. Joseph Health System - Sonoma County 和 Valleycare Health System的总裁、首席执行官,上述两机构都是位于北加州的区域性医院系统。
Robert H. Fish has served as a member of the Board since 2017. Mr. Fish has served, since May 2018 as Chief Executive Officer and, since September 2018 as a member of the board of directors of Quorum Health Corporation, an operator of general acute care hospitals and outpatient services. Prior to joining Quorum Health, he served as Interim Chief Executive Officer of Millennium Health, LLC from January 2018 to March 2018. Mr. Fish also serves as the Chairman of the board of directors of Genesis Healthcare, Inc., a national provider of post-acute healthcare services “Genesis”. Mr. Fish joined Skilled Healthcare Group, Inc., which was later acquired by Genesis, as the Chief Executive Officer in 2013. Mr. Fish served as Skilled Healthcare’s Chief Executive Officer until February 2015 when the combination of Skilled Healthcare and Genesis was completed. During his career, Mr. Fish has served as Chairman, President or Chief Executive Officer of a number of public and private healthcare services companies. From 2012 until he joined Skilled Healthcare in 2013 Mr. Fish served as Managing Partner of Sonoma-Seacrest, LLC, a California health care firm specializing in strategic planning, performance improvement and merger and acquisition matters. Mr. Fish’s prior board positions include serving as the Chairman of REACH Medical Holdings, a regional air medical transport company, from 2008 to 2012 which was acquired by Air Medical Group Holdings; serving as the Executive Chairman of Coram, Inc., a large home infusion provider, from 2005 to 2006 until its sale to Apria; serving as a director of NeighborCare, Inc., a large institutional pharmacy, from 2003 to 2005 until its acquisition by Omnicare; and serving as the Lead Director of Genesis from 2003 to 2007. From 2001 to 2002 Mr. Fish served as a director and subsequently from 2002 to 2003 Mr. Fish served as Chairman and Chief Executive Officer of Genesis Health Ventures, a long-term care and institutional pharmacy company and predecessor in interest to Genesis. Mr. Fish also has extensive experience in hospital administration, having been President and Chief Executive Officer of St. Joseph Health System from 1995 to 1999 and Valley Care Health System from 1985 to 1995 as well as a member of the Board of Directors of the St. Helena Hospital Foundation, a philanthropic organization benefiting the St. Helena Hospitals in Napa Valley, since 2013. Mr. Fish received a B.A. degree in Sociology from Whittier College and a M.P.H. degree in Hospital Administration from the University of California, Berkeley.